Amoxicillin-Clavulanate vs Amoxicillin-Cloxacillin: Key Differences and Guideline Recommendations
Fundamental Mechanism Differences and Spectrum of Activity
- The American Academy of Otolaryngology recommends amoxicillin-clavulanate for its broad-spectrum coverage against β-lactamase-producing organisms, including H. influenzae, M. catarrhalis, E. coli, and S. aureus, with a high effectiveness of 95-100% against H. influenzae and 100% against M. catarrhalis 3, 4
- The addition of clavulanate to amoxicillin preserves its intrinsic activity against S. pneumoniae and adds coverage for β-lactamase-producing organisms, making it suitable for mixed aerobic-anaerobic infections, such as bite wounds, intra-abdominal infections, and diabetic foot infections 5, 2
- Amoxicillin-clavulanate covers β-lactamase and non-β-lactamase-producing strains of S. aureus (MSSA only), E. coli, H. influenzae, Klebsiella species, M. catarrhalis, and anaerobes, including Bacteroides fragilis 3, 4
Guideline-Supported Indications
- The American Academy of Otolaryngology and other major societies recommend amoxicillin-clavulanate as first-choice therapy for lower urinary tract infections, acute bacterial rhinosinusitis, acute otitis media, and non-severe community-acquired pneumonia when amoxicillin alone fails 1, 2, 3, 4
- Amoxicillin-clavulanate is also recommended for diabetic foot infections (moderate severity) requiring coverage for β-lactamase-producing organisms and for animal or human bite wounds requiring anaerobic coverage 5, 2
Dosing Considerations
- The recommended dosing for amoxicillin-clavulanate is 2000 mg amoxicillin/125 mg clavulanate twice daily for adults and 90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses for children, with a 14:1 ratio to minimize gastrointestinal side effects 3, 2, 6
Safety and Tolerability
- Diarrhea is the most common side effect of amoxicillin-clavulanate, significantly reduced with twice-daily dosing and higher amoxicillin:clavulanate ratios (14:1 or 16:1) 6, 2
Resistance Considerations
- Global surveillance shows 75% median resistance of E. coli urinary isolates to amoxicillin alone, supporting the use of amoxicillin-clavulanate for UTIs 1
- High-dose amoxicillin-clavulanate achieves 90-92% predicted clinical efficacy against penicillin-resistant S. pneumoniae in both adults and children 2